Ann: Appendix 4D and Half Year Financial Report, page-7

I am ignorant in this matter but I don't like bland acceptance of expenditure. "not out of line with what pre-revenue clinical-stage pharmas burn" justifies nothing. In fact ours is much less but the situation is different and technically we aren't pre-revenue either. Wayne is a great man to have but that doesn't mean that we can't nag him about expenditure. It is one thing to say "look at the costs I have cut" but I say "look at the costs we have left". My unasked AGM question was "how many people do we have working in marketing". After all at pesent we sell one product to one company.
Helmet on, awaiting inbound!